Delvens published a new research publication on "Human Microbiome Market Insights, to 2030" with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Human Microbiome Market was mainly driven by the increasing R&D spending across the world.
The global Human Microbiome Market size is projected to reach a CAGR of 31.07% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/human-microbiome-market
The human microbiota consists of the trillions of symbiotic microbial cells harbored by each person mainly bacteria in the gut. Microbes, including bacteria, fungi, and viruses, are disease-causing agent that accumulates over time, and the habitat in the gut transforms their genetic activities and metabolic processes, resulting in an abnormal immune response against the substances and tissues that are normally present in the human body. Several microbiome projects have been launched worldwide with the aim to understand the roles played by these symbionts and their impact on the health of human hosts.
Human gut microbiomes play a major role in improving the efficacy of therapeutic compounds. Over the years, studies have shown that the right combination of microbes in the human body is beneficial for treating different conditions. This association between microbes and specific disease states could generate new opportunities for drug developers (or vaccine manufacturers). With several small innovative players operating in the market, there are various high-growth opportunities for key stakeholders to buy out companies so as to study microbiomes in the hope of identifying new drugs and drug targets for various indications, such as obesity, liver disorders, diabetes, and metabolic disorders.
Delvens Industry Expert's Standpoint
The market for human microbiomes is expanding quickly as a result of the increased study of the microbiome and its impact on human health as well as raising public awareness of the possibilities of microbiome-based goods and cures. In order to enhance human health outcomes, there is an urgent need for novel treatment alternatives that can target the microbiome. Chronic disorders including obesity, diabetes, and inflammatory bowel disease are on the rise.
Competitive Landscape
· Rebiotix Inc.
· Yakult Honsha Co., Ltd.
· Synthetic Biologics Inc.
· DuPont
· MaaT Pharma
· Eligo Bioscience
· Merck & Co. Inc
· AOBiome LLC
· Kaleido
· Seres Therapeutics
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/human-microbiome-market
Regional Analysis
Asia Pacific to Dominate the Market
· The Human Microbiome Market in Asia Pacific is estimated to expand at a rapid pace during the forecast period. This expansion of the market in Asia Pacific can be attributed to the high rate of adoption of autonomous forklifts in countries, such as China, which produced maximum number of vehicles across the globe.
· Development of infrastructure and rapid industrialization coupled with expansion of construction and transportation industries are likely to boost the Human Microbiome Market in India and consequently, propel the Human Microbiome Market in Asia Pacific.
Recent Developments
· In 2022, OptiBiotix Health Plc. signed an exclusive sales and distribution agreement with Nahdi Medical Co. To help tackle the obesity epidemic, the company’s GoFigure and SlimBiome Medical weight management products will be available in the KSA from early 2022 through the new agreement with Nahdi.
· In September 2021, PhenoBiome today launched a human gut microbiome assay through Genetic Direction, which will process the assays in its CLIA- and CAP-certified laboratory.
Access Full Report: https://www.delvens.com/report/human-microbiome-market
In addition to the market data for Human Microbiome Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.
Browse More Reports from Delvens:
Hearing Aids market size was estimated at USD 8.9 billion in 2023 and is projected to reach USD 14.2 billion in 2030 at a CAGR of 6.9% during the forecast period 2023-2030.
Maternal Health market size was estimated at USD 23.76 billion in 2023 and is projected to reach USD 61.30 billion in 2030 at a CAGR of 14.50% during the forecast period 2023-2030.
Mapping Catheters market size was estimated at USD 3.07 billion in 2023 and is projected to reach USD 5.46 billion in 2030 at a CAGR of 8.60% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
